Gleave ME - Search Results

1

PARP inhibition in castration-resistant prostate cancer.

Nappi L, Gleave ME. Nappi L, et al. Among authors: gleave me. Future Oncol. 2016 Mar;12(5):577-80. doi: 10.2217/fon.16.1. Epub 2016 Jan 21. Future Oncol. 2016. PMID: 26792387 Free article. No abstract available.

2

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.

Miyake H, Pollak M, Gleave ME. Miyake H, et al. Among authors: gleave me. Cancer Res. 2000 Jun 1;60(11):3058-64. Cancer Res. 2000. PMID: 10850457

3

Novel targets and approaches in advanced prostate cancer.

Hadaschik BA, Sowery RD, Gleave ME. Hadaschik BA, et al. Among authors: gleave me. Curr Opin Urol. 2007 May;17(3):182-7. doi: 10.1097/MOU.0b013e3280dd8a4f. Curr Opin Urol. 2007. PMID: 17414516 Review.

4

In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.

Snoek R, Cheng H, Margiotti K, Wafa LA, Wong CA, Wong EC, Fazli L, Nelson CC, Gleave ME, Rennie PS. Snoek R, et al. Among authors: gleave me. Clin Cancer Res. 2009 Jan 1;15(1):39-47. doi: 10.1158/1078-0432.CCR-08-1726. Clin Cancer Res. 2009. PMID: 19118031

5

Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts.

Locke JA, Nelson CC, Adomat HH, Hendy SC, Gleave ME, Guns ES. Locke JA, et al. Among authors: gleave me. J Steroid Biochem Mol Biol. 2009 Jul;115(3-5):126-36. doi: 10.1016/j.jsbmb.2009.03.011. Epub 2009 Apr 5. J Steroid Biochem Mol Biol. 2009. PMID: 19442514

6

Novel targeted agents on the horizon for castration-resistant prostate cancer.

Koupparis A, Casey RG, Robinson M, Gleave ME. Koupparis A, et al. Among authors: gleave me. Future Oncol. 2010 Dec;6(12):1883-95. doi: 10.2217/fon.10.145. Future Oncol. 2010. PMID: 21142862 Review.

7

Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo.

Thomas C, Zoubeidi A, Kuruma H, Fazli L, Lamoureux F, Beraldi E, Monia BP, MacLeod AR, Thüroff JW, Gleave ME. Thomas C, et al. Among authors: gleave me. Mol Cancer Ther. 2011 Feb;10(2):347-59. doi: 10.1158/1535-7163.MCT-10-0850. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216933

8

MicroRNAs associated with metastatic prostate cancer.

Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y. Watahiki A, et al. PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21980368 Free PMC article.

9

Poly-gene fusion transcripts and chromothripsis in prostate cancer.

Wu C, Wyatt AW, McPherson A, Lin D, McConeghy BJ, Mo F, Shukin R, Lapuk AV, Jones SJ, Zhao Y, Marra MA, Gleave ME, Volik SV, Wang Y, Sahinalp SC, Collins CC. Wu C, et al. Among authors: gleave me. Genes Chromosomes Cancer. 2012 Dec;51(12):1144-53. doi: 10.1002/gcc.21999. Epub 2012 Aug 25. Genes Chromosomes Cancer. 2012. PMID: 22927308

10

Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptor.

Loriot Y, Zoubeidi A, Gleave ME. Loriot Y, et al. Among authors: gleave me. Urol Clin North Am. 2012 Nov;39(4):517-31. doi: 10.1016/j.ucl.2012.07.008. Epub 2012 Sep 1. Urol Clin North Am. 2012. PMID: 23084528 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

652 results

Search Page